GL1X · GenesisL1 explorer

Research workbench

Triazolopyridine-based inhibitor of janus kinase 2

Analyse Triazolopyridine-based inhibitor of janus kinase 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4AQC
Type
protein
Length
588 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
88A, SO4
Pockets
5 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29144% helix, 19% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29742% helix, 19% strandO60674

Ligands and binding sites

  • 88A · 8-(4-methylsulfonylphenyl)-N-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14510.760.845788A
27530.700.7770empty
32060.630.833288A
41210.590.8528empty
5560.340.7814empty

Interfaces

1 interface between chains.

  • A–B · 519 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 4AQC · Triazolopyridine-based Inhibitor of Janus Kinase 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.